Condensed Consolidated Balance Sheets - USD ($)	Sep. 30, 2022	Jun. 30, 2022
CURRENT ASSETS
Cash and cash equivalents	$ 3,648	$ 324,494
Accounts receivable	5,000	5,000
Accrued interest receivable	11,932	7,521
Loan receivable, other	17,380	18,380
Total current assets	37,960	355,395
Property and equipment, less accumulated depreciation of $14,717 and $13,419	21,646	22,944
Notes receivable	350,000	350,000
Total other assets	371,646	372,944
TOTAL ASSETS	409,606	728,339
CURRENT LIABILITIES
Accounts payable	31,438	15,562
Accrued interest	51,953	47,839
Notes payable-third parties	300,000	387,500
Loan payable, related party	2,250	2,250
Debt discounts		(49,863)
Derivative liability	780,071	1,272,799
Total current liabilities	1,165,712	1,676,087
TOTAL LIABILITIES	1,165,712	1,676,087
STOCKHOLDERS’ DEFICIENCY
Common stock; 14,991,000,000 shares authorized, $.0001 par value, as of September 30, 2022 and June 30, 2022, there are 14,488,440,097 and 13,785,662,319 shares outstanding, respectively	1,448,844	1,378,566
Additional paid- in capital Class A common stock	162,913,727	162,732,907
Additional paid- in capital preferred stock	1,385,113	1,385,113
Accumulated deficit	(166,503,793)	(166,444,337)
Total stockholders’ deficiency	(756,106)	(947,748)
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIENCY	409,606	728,339
Series K Preferred Stock [Member]
STOCKHOLDERS’ DEFICIENCY
Preferred stock value
Series L Preferred Stock [Member]
STOCKHOLDERS’ DEFICIENCY
Preferred stock value	$ 3	$ 3